PMDD

Perinatal depression linked with premenstrual mood disorders – new research

Retrieved on: 
Friday, April 5, 2024
Premenstrual dysphoric disorder, Mother, Depression, Death, Health, Prevalence, Disease, Risk, Research, Mental health, Menopause, History, Menstruation, DSM-IV codes, Pregnancy, PMS, Quality of life, Woman, PMDD, Premenstrual syndrome, Fatigue, Irritability, Dixie D'Amelio, Birth control

But for the millions of women who have a premenstrual disorder, such as severe premenstrual syndrome (PMS) or premenstrual dysphoric disorder (PMDD), these mood changes can be far more severe than normal.

Key Points: 
  • But for the millions of women who have a premenstrual disorder, such as severe premenstrual syndrome (PMS) or premenstrual dysphoric disorder (PMDD), these mood changes can be far more severe than normal.
  • Premenstrual disorders manifest through a range of symptoms – including mood swings, irritability and fatigue.
  • Our study found that women who have a premenstrual disorder may also be at greater risk of depression during or after pregnancy.
  • Having a premenstrual disorder may also partly explain why mental health problems may be more common in young women.

Perinatal depression

  • The hormonal fluctuations that happen during and after pregnancy can also precipitate a unique form of turmoil: perinatal depression.
  • Historically, the threads connecting premenstrual disorders and perinatal depression have been recognised anecdotally.
  • We revealed that women with a history of premenstrual disorders are five times more susceptible to developing perinatal depression if they become pregnant.
  • Read more:
    Maternal mental health problems – the impact in numbers

    Moreover, our study is the first to draw connections not just to postnatal depression (depression after childbirth) but also antenatal depression (depression during pregnancy).

  • We also showed that women who experience perinatal depression are at a higher risk of encountering premenstrual disorders later on.

Advocate for mental health

  • It also suggests that women with a history of premenstrual disorders should be closely screened for perinatal depression, and provided with the help and resources they may need for their mental health before and during pregnancy, and just after giving birth.
  • Moreover, it encourages women themselves to advocate for their mental health, armed with the understanding that their experiences before and during pregnancy are not isolated – but part of a broader hormonal narrative that needs addressing.


Donghao Lu receives funding from the Swedish Research Council, Swedish Research Council for Health, Working Life and Welfare, and Karolinska Institutet.

Vistagen Reports Fiscal 2024 Third Quarter Financial Results and Provides Corporate Update

Retrieved on: 
Tuesday, February 13, 2024
Mental Health, Research, Neurology, Clinical Trials, Biotechnology, Health, Pharmaceutical, General Health, Science, Momentum, Social anxiety disorder, Anxiety, SAD, Premenstrual dysphoric disorder, Psychiatry, Safety, Menopause, SUDS, Patient, DSM-IV codes, G&A, MDD, PMDD, NDA, Hot, Pharmaceutical industry

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience to deliver first-in-class therapies for psychiatric and neurological disorders, today reported financial results for its fiscal year 2024 third quarter ended December 31, 2023 and provided a corporate update.

Key Points: 
  • Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience to deliver first-in-class therapies for psychiatric and neurological disorders, today reported financial results for its fiscal year 2024 third quarter ended December 31, 2023 and provided a corporate update.
  • As of February 12, 2024, the Company had 27,029,731 shares of common stock issued and 3,577,240 pre-funded warrants outstanding.
  • Vistagen will host a conference call and live audio webcast this afternoon at 5:00 p.m. Eastern Time to provide a corporate update.
  • In addition, a telephone playback of the call will be available after approximately 8:00 p.m. Eastern Time on Tuesday, February 13, 2024.

Emerging Filmmaker, Mirejah Cruz, Garners Acclaim for Award-Winning Short Film "Hell Week"

Retrieved on: 
Wednesday, February 7, 2024
Anxiety, PMDD, LOS, Depression, Hell week, Mental health, Irritability, PMS, Premenstrual dysphoric disorder, Diagnosis, Film festival, Film industry

LOS ANGELES, Feb. 7, 2024 /PRNewswire/ -- Mirejah Cruz, an up-and-coming actor and filmmaker, is rapidly gaining recognition for her groundbreaking work in the industry. Her latest project, the award-winning short film Hell Week, has captivated audiences and critics alike with its poignant exploration of Premenstrual Dysphoric Disorder (PMDD).

Key Points: 
  • Her latest project, the award-winning short film Hell Week, has captivated audiences and critics alike with its poignant exploration of Premenstrual Dysphoric Disorder (PMDD).
  • The film has resonated deeply with viewers, sparking important conversations about mental health, women's experiences and the medical industry.
  • The film's impact is undeniable, with Hell Week already selected for participation in eight prestigious film festivals, including the California Women's Film Festival and the London International Short Film Festival.
  • Hell Week is directed by Kassandra Mahea, written by Mirejah Cruz and produced by Damon Cirulli and Mirejah Cruz.

Qi Health Revolutionizes Women's Health with Evidence-Based Chinese Herbal Medicine

Retrieved on: 
Monday, November 27, 2023
Patient, PCOS, TCM, Woman, Telehealth, Infertility, PMS, Prescription, Herbal medicine, Fertility, Inflammation, Health, Endometriosis, Chinese herbology, PMDD, Qi, CHM, Female, Traditional Chinese medicine, Medicinal plants

Qi Health introduces the first evidence-based digital health platform for herbal medicine, revolutionizing women's well-being with natural solutions.

Key Points: 
  • New York, New York--(Newsfile Corp. - November 27, 2023) - Qi Health , a cutting-edge digital health platform dedicated to Chinese Herbal Medicine (CHM) emerges from beta today.
  • By connecting patients with certified Traditional Chinese Medicine (TCM) doctors in the United States through video calls, Qi Health brings a transformative approach to women's healthcare.
  • In a world where Traditional Chinese Medicine often faces skepticism, Qi Health relies on rigorous research and evidence-based care.
  • Qi Health's vision extends beyond individual care; it aspires to make Traditional Chinese Herbal Medicine accessible to everyone with unexplained or untreated health issues.

Vistagen Provides Corporate Update and Reports Fiscal 2024 Second Quarter Financial Results

Retrieved on: 
Thursday, November 9, 2023
Biotechnology, Mental Health, Health, Pharmaceutical, Clinical Trials, NDA, CNS, Depression, Safety, PMDD, Hot, Food, Menstrual cycle, DSM-IV codes, PALISADE, Alnylam Pharmaceuticals, Initiate, Menopause, Social anxiety disorder, SAD, Clinical trial, Optimism, Patient, Research, Premenstrual dysphoric disorder, FDA, SUDS, Panic, Anxiety, R, Fasedienol, Central nervous system, MDD, Pharmaceutical industry, Sales, Broadcasting

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous system (CNS) disorders, today provided a corporate update and reported financial results for its fiscal year 2024 second quarter ended September 30, 2023.

Key Points: 
  • Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous system (CNS) disorders, today provided a corporate update and reported financial results for its fiscal year 2024 second quarter ended September 30, 2023.
  • To complement the positive top-line results from PALISADE-2, the Company is preparing to launch two similar Phase 3 clinical trials in 2024, PALISADE-3 in the first half of 2024 and PALISADE-4 in the second half of 2024.
  • She joins Vistagen from Alnylam Pharmaceuticals where she served as the Chief Accounting Officer, focused on strategic and financial operations.
  • Vistagen will host a conference call and live audio webcast this afternoon at 5:00 p.m. Eastern Time to provide a corporate update.

Rittenhouse Psychiatric Associates Expands Services With Hiring of Emily Bernstein, MD - Director of Women's Mental Health

Retrieved on: 
Tuesday, December 12, 2023
Health, PMDD, Philadelphia Eagles, University, Menopause, Dysphoria, Piper, Associate, Mental health, Patient, Pregnancy, Psychiatry, MD, Crozer Health, Medical degree, Neurology, Mental, University of Pennsylvania, Nursing

PHILADELPHIA, Dec. 12, 2023 /PRNewswire/ -- Rittenhouse Psychiatric Associates is proud to announce the continued expansion of their 25-provider team and broadening of their women's mental health services, welcoming Emily Bernstein, MD to their roster of outpatient mental health experts. Dr. Bernstein's focus includes pregnancy treatment planning, postpartum care, premenstrual dysphoric disorder (PMDD) & psychiatric symptoms of menopause.

Key Points: 
  • PHILADELPHIA, Dec. 12, 2023 /PRNewswire/ -- Rittenhouse Psychiatric Associates is proud to announce the continued expansion of their 25-provider team and broadening of their women's mental health services, welcoming Emily Bernstein, MD to their roster of outpatient mental health experts.
  • Dr. Bernstein's focus includes pregnancy treatment planning, postpartum care, premenstrual dysphoric disorder (PMDD) & psychiatric symptoms of menopause.
  • "I'm very excited to join the team here at Rittenhouse Psychiatric Associates," expressed Bernstein.
  • Dr. Bernstein offers her services at Rittenhouse Psychiatric Associate's Paoli, Pennsylvania office and via telepsychiatry to all of Pennsylvania & New Jersey.

Vistagen Announces Positive Results from Exploratory Phase 2A Study of PH80 for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder

Retrieved on: 
Tuesday, September 12, 2023
Biotechnology, Pharmaceutical, Health, Clinical Trials, Central nervous system, Depression, AE, Anxiety, Aes, Premenstrual dysphoric disorder, CNS, DSR, Menstrual cycle, PMDD, Headache, Safety, PMTS, Pharmaceutical industry, Copper

At the second study visit, subjects were randomized to receive a single dose of 0.9 µg PH80 nasal spray or placebo in the clinic.

Key Points: 
  • At the second study visit, subjects were randomized to receive a single dose of 0.9 µg PH80 nasal spray or placebo in the clinic.
  • The previously unreported results of this exploratory Phase 2A clinical study of PH80 signal a potential revolutionary method for treating premenstrual mood symptoms,” said Shawn Singh, Chief Executive Officer of Vistagen.
  • “PMDD symptoms can be extremely limiting to daily functioning and PH80 demonstrated the potential to alleviate these symptoms.
  • Vistagen gained access to the results of the study in connection with its acquisition of Pherin in February 2023.

Periods and Exercise: INTIMINA Survey Reveals Women's Exercise Habits During Menstruation

Retrieved on: 
Tuesday, July 19, 2022
Social media, Progesterone, Menstruation, Woman, Pelvic floor, Menstrual cycle, PMS, Hormone, Exercise, Cramp, Pain, Eating, PMDD, Diet, Awareness, SAN, Birth control, Dietary supplement

SAN JOSE, Calif., July 19, 2022 /PRNewswire/ -- Women often ask if they should be exercising while menstruating. While expert advice supports how exercise reduces pain and cramps, there remains the myth about needing to rest during your period.

Key Points: 
  • While expert advice supports how exercise reduces pain and cramps, there remains the myth about needing to rest during your period.
  • To further understand how menstruation affects women's readiness to exercise and train, international women's healthcare brand, INTIMINA , surveyed their social media followers to ask them to share exercise habits during menstruation.
  • The survey surprisingly uncovered that most women (79%) take a day off from exercise when their period starts.
  • "Tracking your sleeping, eating and exercise habits to take a personalized approach to your diet and exercise program can help, as this is likely to improve your exercise performance," saysDr.

Gabrielle Pesaturo, PMHNP-BC Joins South County Psychiatry's Massachusetts Practice

Retrieved on: 
Tuesday, May 24, 2022
Dementia, Obsessive–compulsive disorder, Anxiety, Lists of diseases, CBT, Dialectical behavior therapy, Rhode Island Hospital, Psychiatric-mental health nurse practitioner, Patient, Tic disorder, University, Profile, MCPHS University, Premenstrual dysphoric disorder, Adult, Bipolar disorder, Depression, Telehealth, Psychotherapy, Bachelor of Science in Nursing, PTSD, OCD, ADHD, Bradley Hospital, Autism, United States Public Health Service, Post-traumatic stress disorder, NORTH, Mental health, Outline of health sciences, Attention deficit hyperactivity disorder, Nursing, PMDD, Medicine, Meat, MD, Science, Pharmacy

NORTH KINGTOWN, R.I., May 24, 2022 /PRNewswire-PRWeb/ -- Gabrielle Pesaturo, a Board-Certified Psychiatric Mental Health Nurse Practitioner, has joined South County Psychiatry, which recently expanded its practice area to serve patients in Massachusetts.

Key Points: 
  • Gabrielle Pesaturo, a Board-Certified Psychiatric Mental Health Nurse Practitioner, has joined South County Psychiatry, which recently expanded its practice area to serve patients in Massachusetts.
  • NORTH KINGTOWN, R.I., May 24, 2022 /PRNewswire-PRWeb/ -- Gabrielle Pesaturo, a Board-Certified Psychiatric Mental Health Nurse Practitioner, has joined South County Psychiatry , which recently expanded its practice area to serve patients in Massachusetts.
  • "We couldn't be prouder to welcome Gabrielle to our team," said Dr. Anthony Gallo, psychiatrist, and founder of South County Psychiatry.
  • We are thrilled that she has chosen South County Psychiatry as the practice that best matches her aims as a mental health care practitioner."

Global Amino Acids Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Friday, February 4, 2022
Retail, Health, Fitness & Nutrition, Agriculture, Natural Resources, Food, Beverage, Food, ADHD, Immune system, Consultant, Sport, Athlete, Red meat, Egg, Biotechnology, Hormone, PMDD, COVID-19, Dairy, Cancer, Attention deficit hyperactivity disorder predominantly inattentive, Animal, Rectum, Energy, Premenstrual dysphoric disorder, Seafood, Bruxism, Sleep, SWOT, Depression, Industry, Smoking cessation, Protein, Amino acid, Organic acid, Porter's five forces analysis, Dietary supplement, Fine chemical

What has been the impact of COVID-19 on the global amino acids market?

Key Points: 
  • What has been the impact of COVID-19 on the global amino acids market?
  • What are the various stages in the value chain of the global amino acids market?
  • What are the key driving factors and challenges in the global amino acids market?
  • What is the structure of the global amino acids market and who are the key players?